S-F-LNT: The innovative core of a new generation of functional sugar biologics CAS: 84061-53-0

Today, when glycobiology, precision nutrition, and biomedicine are intertwined, sugar chains, as important information molecules in life, are constantly being decoded and empowered. Monosialyl, Monofucosyllacto-N-tetraose (hereinafter referred to as S-F-LNT) is one of the shining stars. As a key and structurally unique type of sialylated fucosylated complex sugar in human milk oligosaccharides (HMOs), it is not only an important nutritional and protective factor for infant and young child development, but also shows great application potential in the fields of disease intervention, drug delivery, and immune regulation.

Chemical Information

Chemical name: Monosialomonofucosyllactose-N-tetrasaccharide

Common names/abbreviations: S-F-LNT, Monosialyl Monofucosyllacto-N-tetraose

Chemical formula: C₄₃H₇₂N₂O₃₃

Molecular weight: 1145.03 g/mol

CAS number: 84061-53-0

Structural features: exquisite sugar chain "smart password"

S-F-LNT is not a simple series connection of sugar units, its structure contains precise biological logic:

Triple functional module integration: This molecule cleverly integrates the lactose-N-tetrasaccharide (LNT) core skeleton, a fucose (Fucose) terminal modification and a sialic acid (usually N-acetylneuraminic acid) terminal modification. This combination enables it to possess multiple biometric signals at the same time.

The key synergy between sialic acid and fucose: The negative charge and steric hindrance brought by sialic acid, as well as the unique hydrophilicity and recognition properties of fucose, and the specific arrangement of the two in space (such as the formation of Sialyl Lewis x epitope), make it a high-affinity ligand for many cell surface lectin receptors (such as the selectin family).

Structural isomerism and functional specificity: The connection positions of sialic acid and fucose on the core of the sugar chain (such as α2,3 or α2,6 sialic acid connection, α1,2, α1,3 or α1,4 fucose connection) can form different isomers, each of which may correspond to a unique function and receptor recognition spectrum, which is the structural basis for precise biological effects.

Main applications and advantages

1. Core functional ingredients for high-end infant nutrition and health

The gold standard for simulating human breast milk: S-F-LNT is a bioactive oligosaccharide naturally occurring in human milk. It directly provides immune and probiotic ingredients closest to breast milk to formula milk, supporting the development of the newborn's immune system, intestinal flora colonization and barrier function maturation.

Dual biological activity: Sialic acid is the precursor of brain gangliosides and sialoglycoproteins, which is crucial for cognitive development; fucose can specifically inhibit the adhesion of pathogens (such as Helicobacter pylori and rotavirus) in the intestinal mucosa, acting as a "bait" receptor, providing direct protection.

The key to differentiation of the next generation of formula milk powder: Beyond basic nutrition, adding specific structure S-F-LNT is a strategic raw material to achieve functional and precise upgrading of formula milk powder to meet the high-end demand of the consumer market for "closer to breast milk".

2. Innovative tools for disease intervention and drug development

Anti-inflammatory and immunomodulator: As a natural ligand of selectins (such as E-selectin, P-selectin), S-F-LNT can competitively inhibit excessive adhesion of leukocytes and vascular endothelial cells. This process is a key step in acute and chronic inflammation, autoimmune diseases and cancer metastasis. Therefore, it is a valuable starting point for the development of novel anti-inflammatory, anti-metastatic lead compounds.

Targeted drug delivery system: Utilizing its ability to specifically recognize cell surface receptors, S-F-LNT or its derivatives can be used as a "navigation head" and modified on liposomes, nanoparticles or drug molecules to achieve targeted delivery to specific inflammatory sites or tumor tissues, improving efficacy and reducing side effects.

Prevention and treatment of infectious diseases: By blocking the adhesion of pathogens, S-F-LNT can be developed as a biological inhibitor to prevent or assist in the treatment of gastrointestinal and respiratory tract infections, especially for infants and young children and people with low immunity.

3. Probes for cutting-edge biomedical research and diagnosis

Study on glycobiological mechanisms: Highly pure S-F-LNT is a key molecular tool for studying the role of sialylation and fucosylation modifications in cell communication, signal transduction, development and disease. Used to explore basic life processes such as receptor-ligand interactions and immune recognition.

Disease biomarkers and detection: In certain disease states (such as cancer, inflammatory diseases), the level of specific S-F-LNT structures or related synthase activities in the body will change. It can serve as a potential disease marker or be used to develop highly sensitive clinical diagnostic tests.

Synthetic biology and enzyme engineering research: As a typical representative of complex natural sugar chains, it is an important standard and target product for testing and optimizing new glycosyltransferases and constructing cell factories to synthesize complex HMOs.

Conclusion

Monosialomonofucosyllactosyl-N-tetrasaccharide (S-F-LNT), is much more than just one sugar molecule. It represents the evolutionary wisdom of nutrition in early life, is a chemical bridge connecting immunity, nerves and microbiota, and is a key to unlocking new ideas for targeted treatment of inflammation and cancer. From empowering the next generation of infant products to driving innovative drug research and development, its value is crossing the boundaries of nutrition and medical care.

The above information is provided by the editor of KASONS and is for scientific research only.